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Evaluation of the Therapeutic Management of Childhood Diarrhea 
Ana F. Diallo PhD 
University of Connecticut, 2016 
Therapeutic management of childhood diarrhea had led to a significant decrease in diarrhea 
related morbidity and mortality. However, diarrhea diseases remain one of the leading cause of 
preventable deaths worldwide, especially in children under 5 years. The work presented in this 
dissertation intended to evaluate the current the management of childhood diarrhea, to identify 
the major gaps in the management and introduce a novel approach to address these gaps. First, an 
assessment of oral rehydration therapies (ORT) coverage in the management of childhood 
diarrhea is performed to evaluate healthcare providers’ prescriptive practices of ORT in South 
Asia. Next, we assess the effect of breastfeeding cessation in reported episodes of diarrhea using 
a national database. The study highlighted suboptimal breastfeeding practices among American 
mothers who participated in the study and its impact on reported onset of diarrhea episodes in 
infants during their first year of life. The results show that breastfeeding cessation before the first 
6 months is a significant predictor of diarrhea between 7 and 12 months. Lastly, sensitivity of a 
diarrheagenic pathogen identification tool was tested in two laboratory simulated environments. 
Despite the limitation of the experiments, the study offers insight of the tool’s properties under 
specific environment, guiding future optimization. The manuscripts comprised in this 
dissertation provide evidence for the need to re-evaluate the use of therapies known to be 
effective and to conduct future research in innovative approach to the management of childhood 
diarrhea. 
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Allow yourself to dream, 
And when you do dream big 
Allow yourself to learn 
And when you do learn all you can 
Allow yourself to laugh 
And when you do share your laughter 
Allow yourself to set goals 
And when you do reward yourself as you move forward 
Allow yourself to be determined 
And when you do you will find you will succeed 
Allow yourself to believe in yourself 
And when you do you will find self confidence 
Allow yourself to lend a helping hand 
And when you do a hand will help you. 
Allow yourself relaxation 
And when you do you will find new ideas. 
Allow yourself love 
And when you do you will find love in return 
Allow yourself to be happy 
And when you do you will influence others around you. 
Allow yourself to be positive 
And when you do life will get easier. 
                                                 Catherine Pulsifer 
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1.1 Childhood diarrhea: etiology and burden 
Accounting for 9% of all death worldwide, approximately 578,000 children under the age 
of 5 die from infectious diarrhea each year (Liu et al., 2015). Childhood diarrhea is chiefly 
manifested as a symptom of intestinal tract infections. There are three major factors that must be 
considered when defining diarrhea: the frequency of stool output, stool consistency and stool 
weight (Pawlowski, Warren, & Guerrant, 2009). According to the World Health Organization 
(WHO), diarrheal diseases is defined as followed: 
“The passage of three or more loose or liquid stools per day, or more frequently than is 
normal for the individual.”(World Health Organization, 2013) 
Over the past 30 years, the therapeutic management of childhood diarrhea has led to a significant 
decrease in under-five mortality. It has been estimated that mortality rates related to diarrheal 
infections decreased by more than two fold, from 1.2 million in 2000 to half a million in 2015 
(United Nations Children’s Funds, 2016).4 Even though this is a significant decrease, many of 
these deaths are preventable with appropriate management strategies.  
While child mortality has significantly decreased, diarrheal infections remain one of the 
leading cause of death in children under the age of 5. Approximately 1.7 million episodes of 
childhood diarrhea are reported each year, with 1,600 deaths occurring daily (Liu et al., 2015). 
The majority of the burden caused by diarrheal diseases occur in low and middle income 
countries where pathogen transmission occurs mainly through overcrowding, poor sanitation, 
limited access to clean water and inadequate food hygiene (Leung, Chisti, & Pavia, 2016). South 
Asia and Sub Saharan Africa alone account for 90% of the total childhood mortality rate due to 
diarrhea (Liu et al., 2015).  
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Diarrhea is caused by a number of pathogens including bacteria, viruses, protozoa and 
helminths (Larson, Henning, Luby, & Faruque, 2009). A multiple sites birth cohort study (MAL-
ED) was conducted in eight different countries in South America, Sub-Saharan Africa and South 
Asia between 2009 and 2014 to estimate the pathogen-specific burdens of diarrhea in children 
between 0 to 2 years of age (Platts-Mills et al., 2015). The researchers reported that cases of 
acute to persistent diarrhea in children under 2, were mainly attributed to norovirus, rotavirus, 
Campylobacter spp, astrovirus and Shigella spp (Platts-Mills et al., 2015). Factors such as age, 
location and climatic variability were also reported to have a significant impact on the incidence 
of diarrhea.  The authors (2015) concluded that significant reduction in the incidence of 
childhood diarrhea, at the community level, could only be achieved by diversifying the diarrhea 
control programs rather than focusing on a single-pathogen strategies.  
1.2 Classification of diarrhea 
Due to financial and technical constraints, diarrheal infections are often managed on the 
basis of clinical symptoms rather than the identification of etiologic pathogens (Larson et al., 
2009) Diarrheal diseases can be classified in three major categories based on the clinical 
presentations. They are: 1) acute watery diarrhea, 2) persistent diarrhea and 3) bloody diarrhea. 
Each category is physiologically different, hence requiring specific diagnosis and management.  
Acute watery diarrhea, also described as secretory diarrhea, is characterized by symptoms lasting 
for less than 2 weeks (Pawlowski et al., 2009). It is mainly associated with small bowel 
infections resulting in a decrease sodium absorption and an increase mucosal permeability as 
well as chloride secretion (Pawlowski et al., 2009). The inflammatory process causes severe, 
acute dehydration and electrolyte imbalance.  
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Persistent diarrhea is diagnosed when an episode lasts for 2 to 4 weeks (Pawlowski et al., 
2009). Commonly caused by the inflammation of the small bowel, this type of diarrhea is 
associated with nutritional malabsorption and chronic malnutrition. Children with persistent 
diarrhea accompanied with chronic malnutrition can suffer from stunting, vitamin A deficiency, 
other systemic infections and more severe diarrhea; setting them up in a viscious cycle (Keusch 
et al., 2006). That is the reason why persistent diarrhea significantly increases the case- fatality 
rates and have long-lasting impact on the quality of life (Keusch, Walker, Das, Horton, & Habte, 
2016) 
Bloody diarrhea, interchangeably called dysentery in the clinical setting, is commonly 
associated with dehydration and fever (Keusch et al., 2006) This type of diarrhea is characterized 
by traces of blood in the stool and is indicative of intestinal damage secondary to an 
inflammation of the colon or distal part of the small intestine (Keusch et al., 2006; Keusch et al., 
2016; Pawlowski et al., 2009).  
Based on these classifications, clinical management of childhood diarrhea has focused 
primarily on the prevention and reduction of dehydration with oral rehydration therapy (ORT), 
zinc supplementation and the maintenance of oral feeding, especially breastfeeding when 
possible (World Health Organization, 2005). These preventive measures have been proven to 
decrease stool output, frequency and duration of diarrhea episode. ORT and breastfeeding, 
mainly, are described as the major contributors to the significant drop in childhood diarrhea 
worldwide. The subsequent sections present, in more details, the properties and roles of ORT and 
breastfeeding in the management of childhood diarrhea.  
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1.3 Preventive and therapeutic management of childhood diarrhea 
1.3.1 Oral rehydration therapy 
The updated WHO guidelines on the clinical management of childhood diarrhea suggest 
the use of low osmolality ORT containing decreased glucose and sodium concentrations (World 
Health Organization, 2005). Studies demonstrated that the reduced osmolarity of oral rehydration 
was safer than the original formulation of ORT and has been reported to decrease stool output by 
20% (Hahn, Kim, & Garner, 2002). Recommendations for healthcare providers include 
prescribing the solution volume based on the child’s weight and presenting signs of dehydration.  
Oral rehydration works through several different mechanisms of the GI track. Intestinal 
absorption of fluids and electrolytes results from ion transport processes across the trans-
epithelial cell membrane (absorptive and secretory) and osmosis. Osmotic gradient is dictated by 
sodium (Na+) transport (Figure 1) (Suh, Hahn, & Cho, 2010). Absorption of the organic solutes 
(sugar, oligopeptide and amino acid) is accompanied with the absorption of Na+, which results in 
water absorption via osmosis (Field, 2003). 
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Figure 1. ORT mechanism. During an episode of diarrhea, there is massive loss of water and electrolytes mainly, 
sodium ions (Na+). Coupled transport of sodium and glucose is preserved. Glucose facilitates Na+ reabsorption 
(water follows) back into the cell on a 1:1 molar basis against concentration gradient through the glucose symporter, 
sodium-glucose transporter type 1 (SGLT1). Na+ present in the epithelial cells is then pumped into the blood via 
adenosine triphosphate (Na+K+ATPase). Transport of glucose into the blood is mediated by the glucose transporter 2 
(GLUT2). (Duggan, Fontaine, Pierce, & et al., 2004). 
During an episode of diarrheal infection, there is disruption of these mechanisms, with 
the exception of the sodium absorption coupled with sugars and amino acids process (Suh et al., 
2010). The integrity of the latter mechanism in diarrheal diseases was discovered in the 1960’s 
and has been the theoretical foundation of oral rehydration therapy (ORT) (Hoque, Chakraborty, 
Sheikh, & Woodward, 2012) Considered the most important medical advance of the 20th century, 
ORT has been the cornerstone in the prevention and management of childhood diarrhea 
(Santosham et al., 2010).  
 Despite the success of the early diarrhea-control programs and the updated World Health 
Organization guidelines, many children under the age of 5 still do not receive adequate treatment 
during an episode of diarrhea. Recent reports indicated that only 40% of children suffering from 
diarrhea worldwide, received oral rehydration or increased fluid intake with continued feeding as 
part of their management (United Nation Children’s Funds, 2016). It is important to note, that 
this degree of treatment is only 10% greater (approximately) than the 1995 global percentage of 
children under 5 years who received oral rehydration as treatment for their diarrhea episode 
(Fontaine et al., 2009). Even though ORT has been proven to be effective it is still not used 
routinely by all health professionals worldwide in the management of childhood diarrhea.  
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1.3.2 Breastfeeding 
Since 1984, breastfeeding has been identified as one of the most important and cost-
effective intervention, significantly preventing and reducing the incidence of infectious diseases 
in children, especially diarrhea and pneumonia (Field, 2003; Hoque et al., 2012; Suh et al., 
2010). Human breastmilk contains bioactive molecules, mostly secretory antibodies, lactoferrin 
and glycans promoting protection and maturation of the gastrointestinal track and immune 
system during infancy and early childhood (Brandtzaeg, 2010; Lamberti, Fischer Walker, 
Noiman, Victora, & Black, 2011; Newburg, 2000; Zivkovic, German, Lebrilla, & Mills, 2011). 
Exclusive breastfeeding during the first 6 months of life has been reported to offer the 
best immune protection against diarrheal diseases. In a systematic review of the literature, 
Lamberti and colleagues (2011) assessed the protective effect of optimal versus suboptimal 
breastfeeding practices on diarrhea associated childhood morbidity, mortality and hospitalization 
in low income countries. The study findings indicated that among infants between 0 and 5 
months, those who were partially breastfed had 1.68 times (95% Confidence interval [1.03-2.76]) 
greater risk of having diarrhea compared to those who were exclusively breastfed (Lamberti et 
al., 2011). The risk of hospitalization from diarrhea was 6.05 times greater in infants between 6 
and 11months who were not breastfed compared to those who were breastfed (Lamberti et al., 
2011).  
While the protective effect of breast milk is undeniable, significant gaps still exist in the 
promotion and practice of early breastfeeding initiation and continuation for the first 6 months of 
life, even in countries like the US. Non-exclusive or early interruption of breastfeeding, also 
known as suboptimal breastfeeding, was ranked in 2010 by the Global Burden of Disease Study 
as the second leading risk factor of disease burden in children under the age of 5 worldwide 
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regardless of whether the child was in a developed or under-developed country (Gaffney, 
Kitsantas, & Cheema, 2012). 
1.4 Overall goal of the dissertation 
Even with these known findings and recommendations about how to prevent and manage 
childhood diarrhea, a gap in the use of evidence-based practice strategies remains. The limited 
use of oral rehydration solutions and exclusive breastfeeding practices for more than three 
decades has been linked to the diversion of international funding towards malaria and AIDS after 
the incorporation of diarrhea-control programs into the integrated management of childhood 
illness (IMCI) approach (Fontaine et al., 2009). This incorporation of the diarrhea-control 
programs into the integrated management of childhood illness (IMCI) has led to inconsistencies 
in healthcare professionals training specific to diarrhea management (Fontaine et al., 2009). 
Also lacking in the management of diarrhea in limited recourses settings is the diagnosis 
based on laboratory testing. Current clinical management of diarrheal episodes are mostly 
symptoms based (Kotloff et al., 2013). The diagnosis and treatment based only on clinical 
symptoms can be inaccurate and result in the unnecessary use of broad spectrum antibiotics 
(Pathak, Pathak, Marrone, Diwan, & Lundborg, 2011; Reddington, Tuite, Minogue, & Barry, 
2014). There is, therefore, a critical need to develop a point-of-care pathogen identification tool 
enabling fast and accurate identification of diarrheal pathogens.  
The overall goal of this dissertation is to address these gaps and introduce a novel 
approach in the management of diarrhea by healthcare professionals. The two studies reported in 
chapter two and three examine the limited use of interventions such as ORT and breastfeeding in 
the management of childhood diarrhea. The focus was only on these interventions because of 
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their scientifically proven efficacy, their low to no cost value and their known success for more 
than 30 years.  
The two studies shed some lights on the limitations of the current diarrhea-control 
programs. A systematic review of the literature has been performed in chapter two, to assess the 
reported management of childhood diarrhea by trained physicians and pharmacists in South Asia; 
where coverage of ORT increased by only 5% from 2000 to 2015 (United Nation Children’s 
Funds., 2016).  
The study presented in chapter three explores the protective effect of breastfeeding on 
diarrhea outcomes during the first year of life, using a large cohort of infants in the United 
States. The findings of the secondary data analysis suggest statistically strong evidence for the 
protective effect of breastfeeding on the incidence of diarrheal episodes. The results also show 
that suboptimal breastfeeding remains a public health issue even in developed countries like the 
US.  
Finally. The third study reports on the laboratory testing of a paper-based diarrheagenic 
pathogens identification tool. The aim of this pilot study is to evaluate the effectiveness of a new 
pathogen identification tool by determining it’s efficacy in identifying a common diarrheagenic 
pathogen, E coli, under high temperature range; simulating the climate in the geographical areas 
with the highest morbidity and mortality rates due to diarrhea. Such a tool has the potential to 
help formulate accurate diagnosis and effective treatment of children suffering from diarrhea in a 
timely manner, thus reducing the impact of diarrhea on childhood morbidity and mortality.  
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1.5 Specific aims and hypotheses 
Specific aim for study #1: To describe the use of ORT in the management of childhood 
diarrhea by physicians and pharmacists as reported in observational studies performed in South 
Asia. Hypothesis: In cases of childhood diarrhea, physicians and pharmacists will prescribe ORT 
in limited proportions. Healthcare professionals (mainly physicians, pharmacists, midwives and 
nurses) at the public and private levels play an important role in the management of childhood 
diarrhea. Recent studies performed in South India and Sub-Saharan Africa  have shown that, 
regardless of receiving formal diarrhea management training,  healthcare professionals treating 
children with diarrhea tended to prescribe more antibiotics, injections and anti-diarrheal 
medications than oral rehydration solutions and zinc (Pathak et al., 2011; Sood & Wagner, 
2014). 
Specific aim for study #2: To evaluate the impact of breastfeeding duration during the 
first 6 months after birth, on the maternal reports of diarrhea episodes in infants during their first 
year. Hypothesis: Compared to infants who discontinued breastfeeding between 0 and 6 months, 
the infants who were breastfed up to 6 months or longer will have a lower count of diarrheal 
episodes, reported by mothers within 2 weeks prior to completion of questionnaires at 7, 9, 10, 
and 12 months. Multiple studies have shown that breastfeeding, the recommended source of 
nutrition for at least the first six months of life, is essential for the nutritional, immunologic, 
neurobehavioral and social development of the infant and young child (Group, 2016; Gupta, 
Dadhich, & Suri, 2013). 
Specific aim for study #3: To evaluate the efficacy of a pathogen identification tool in 
detecting the presence of E. coli under simulated high temperature conditions similar to limited 
resources settings with the highest morbidity and mortality rates due to diarrhea. Hypothesis: The 
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pathogen identification tool will accurately detect diarrheagenic pathogens under environmental 
conditions that are specific to the region of the worlds most affected by diarrheal diseases. This 
hypothesis is based on results of preliminary laboratory evaluation of the pathogen identification 
tool.  
To address the growing interest to develop diagnostic technologies targeting low-resource 
settings, the WHO has outlined in seven points the characteristics point-of-care tests should have 
(Kettler, White, & Hawkes, 2004; Mabey, Peeling, Ustianowski, & Perkins, 2004). 
Corresponding to the acronym “ASSURED”, these tests should be: 1) affordable, 2) sensitive, 3) 
specific, 4) user-friendly, 5) rapid and robust, 6) equipment-free, and 7) deliverable to end users 
(Kettler et al., 2004). The successful completion of this study is in line with these criteria and is 
expected to further optimize a point-of-care diarrhea pathogen identification tool appropriate to 
resource-limited sites.  
1.6 Conclusion 
Inappropriate management of diarrhea episodes contribute to the slow progress made in 
the last four decades to reduce mortality and morbidity due to diarrheal diseases. The findings of 
each study presented in this dissertation will contribute to the understanding of the most current 
management of childhood diarrhea and identify the gaps justifying the need to develop 
alternative approach to continue reducing the impact of diarrhea in children. The development of 
point-of-care diagnostics at the service of global health issues is critical to address the gap in 
using adequate management measures, hence improving child survival and reducing morbidity 
and mortality rates caused by diarrheal diseases. 
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Abstract 
Background: Oral rehydration therapies (ORT) has been the cornerstone of diarrheal control 
programs and is associated with a significant drop in diarrhea related childhood mortality. 
Despite the proven evidence and low cost, routine use of ORT remains limited.  
Objectives: A systematic review of the literature was performed to evaluate healthcare providers 
(medical doctors and pharmacists) ORT prescriptive practices during management of childhood 
diarrhea. 
Method: A meta-analysis of observational studies reporting on medical doctors and pharmacists 
prescribing behaviors during management of childhood (ages 0 to 15 years) diarrhea in South 
Asia was the initial intent of this work. Statistically significant evidence of study heterogeneity 
was achieved, not allow for combining data across studies. Therefore, an integrative review was 
completed following PRISMA guidelines. An electronic search was performed using PubMed, 
Embase, Ovid Global Health and the World Health Organization (WHO) Global Health Library. 
Studies reporting on healthcare providers’ ORT prescriptive practices during management of 
diarrhea South Asia were included.  
Results: Eighteen studies were included in the review. The lack of robust evidence and inability 
to combine the findings in a meta-analysis were due to variations between studies’ design, 
method, population and geographical settings. Overall study findings demonstrated considerable 
variability in ORT coverage that was consistent regardless of publication before or after the 2004 
WHO guidelines for the management of childhood diarrhea. Pharmacists and/or pharmacy 
personnel were reported to prescribe lower rates of ORT compared to medical doctors and/or 
health facilities workers.  
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Conclusions: Available evidence demonstrates limited use of ORT during management of 
childhood diarrhea by health providers in South Asia and that it is inconsistent with the 2004 
WHO guideline. Variability in the study methodologies, designs, settings and reporting was 
significant. Findings highlight the need for stronger study methodologies specifically related to 
sampling, measurement and reporting of ORT in management of childhood diarrhea. 
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2.1 Introduction 
Worldwide, childhood mortality due to diarrheal diseases has dramatically decreased 
from 4.6 million in 1980 to 526, 000 in 2015.1 This significant drop is primarily due to the 
improved therapeutic management of diarrheal diseases which mainly includes: oral rehydration 
therapy (ORT), zinc supplementation, and antibiotics for dysentery. Additional supportive 
interventions include routine use of the rotavirus vaccine, vitamin A supplementation, initiation 
and maintenance of breastfeeding, access to clean water, and hand washing with soap and water.2 
Use of ORT alone as the first line treatment has the potential to reduce diarrhea mortality rates 
by approximately 93 percent.3 
Since the 1970’s, the World Health Organization (WHO) has continuously recommended 
ORT for the prevention and treatment of dehydration caused by diarrhea.4  Over time, the 
formulation of ORT has been extensively studied and refined to optimize reduction of stool 
output while at the same time minimizing vomiting and other side effects such as 
hypernatremia.4  Three decades of research have provided strong evidence to support the 2004 
WHO recommendation for the use of a low osmolality ORT from 311mOsm/l (90mEq/L of 
sodium) to 245mOsm/l (75mEq/l of sodium).5 The new formulation has been proven to reduce 
stool output, vomiting, and the need for intravenous rehydration.3 Even with the existing 
recommendations, many children suffering from diarrheal diseases do not receive ORT, the 
appropriate recommended treatment.6  
Regardless of the proven efficacy, low cost, and ease of use, the rate of ORT prescription 
in the management of diarrheal episodes in the clinic setting or in the home remains stagnant. It 
is estimated that worldwide only about 40% of children under the age of 5 suffering from 
diarrhea receive ORT for the treatment of childhood diarrhea.6 For example, between 2000 and 
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2015 the use of ORT increased by only 4% (from 48% to 52%) in South Asia.  As a 
consequence, about 4.7 million episodes of childhood diarrhea are reported each year and 
approximately 1,600 deaths associated with diarrhea occurring daily in South Asia.1  
We performed a meta-analysis and integrative review to evaluate medical doctors and 
pharmacists’ prescription of ORT in the management of childhood diarrhea in South Asia. We 
chose South Asia as it is one of the regions of the world with the highest rate of childhood 
mortality due to diarrhea.6 The study focuses only on observational study designs published 
between 1988 and July 2016 to allow exploration of medical doctors and pharmacists’ ORT 
prescription practices, in their natural setting, without an alteration of behaviors and patterns.8-10  
We used Lipsey and Wilson method of meta-analysis (2001) to answer the following research 
question:  
What are the medical doctors and pharmacists’ ORT prescription behaviors as reported in 
published observational design studies? 
2.2 Method 
2.2.1 Study retrieval 
After problem statement formulation and eligibility criteria were confirmed, a literature 
search was performed according to the Lipsey and Wilson method.10   Initial eligibility criteria 
included research with an observational study design, published in English language and 
research respondents being children under the age of 15 suffering from diarrhea or any 
healthcare professionals providing treatment for childhood diarrhea.  
The literature search was completed using five different databases including Pubmed, 
Scopus, WHO Global Health Library as well as PsychInfo and Sociological abstract. The search 
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also included screening of references in related review articles and eligible studies. The 
keywords and mesh terms used in combination were oral rehydration therapy, fluid therapy, oral 
rehydration salts, oral rehydration solutions, sugar and salt solutions, diarrhoea, diarrhea, 
chronic diarrhea, acute diarrhea, children, childhood, infant, toddler and pediatric. To ensure 
that each study was comparable to the others and provided a consistent effect size statistic, 
critical to producing strong analytical results, the literature search was further narrowed to the 
health professional groups that were the most frequently reported in the studies to choose ORT 
for diarrheal treatment; medical doctors and pharmacists.  
2.2.2 Selecting, computing and coding the effect size statistics 
Eligible studies were independently reviewed by two authors who then met to further 
discuss inclusion of each study. The final selection was completed after the third reviewer 
adjudicated on any uncertainty and disagreement about inclusion and exclusion. The encoding 
process was then used for data extraction and to further organize each study’s findings. The 
extracted data included information about: geographical location for study recruitment; the study 
population; design; study objective; interventions; outcomes; and reported effect size statistics.10 
Proportions of prescribed ORT during the management of childhood diarrhea by medical doctors 
and/ or pharmacists were extracted and organized in a Microsoft (MS) Excel spreadsheet. The 
standardized mean difference effect sizes, correlation coefficients, odds ratio and homogeneity 
were computed using Excel and Statistical Package for Social Sciences (SPSS, version) Macros 
programs.10 
Despite the extensive literature retrieved related to diarrheal management, a high degree 
of variability was noted between studies in terms of methodologies and designs, intervention and 
study population. Statistically significant heterogeneity was detected (Q = 87.70, p = 6.83x 10-
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19); which does not allow for combining of the studies’ findings for further analyses. As 
illustrated in Table 1, the nature of reported outcomes differed from one publication to the other. 
Therefore, the authors moved on to completing an integrative review of the literature following 
the PRISMA guideline to further delineate the study findings.11 The review focused on 
describing the results of observational studies describing the prescription of ORT in the 
management of childhood diarrhea in children under 15 years old by health professionals with 
formal and informal health training in South Asia.  
2.3 Results 
2.3.1 Study characteristics 
The literature search yielded 4442 articles from the different databases and reference 
lists. Of those articles, 2917 were excluded after removing duplicates and articles published in 
non- English language outside of the study period. Titles and abstracts of 1525 articles were 
screened for the initial eligibility criteria. Limiting the review to South Asia and study design and 
methodology, 1433 articles were excluded and 92 articles were identified for full article review 
by two co-authors. Based on the review and discussion, 74 did not meet the additional eligibility 
criteria mainly because they did not separate prescription practices based on the healthcare 
providers’ groups. In total, 18 articles were included in the analysis after limiting the eligibility 
criteria to medical doctor and/or pharmacists. See PRISMA Diagram for details of study 
selection process (Figure 1).  
Of the 18 studies, seven were published before 2004 and 50% were studies performed in 
India (n = 9). In six articles, the study’s method and design was not specified while nine were 
surveys.  Respondents in the majority of the studies (n = 10) were medical doctors and/or 
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pharmacists and their prescribing behaviors while the remaining studies focus on children 
suffering of diarrhea and their caregivers’ reports. The age of the children varied with majority 
referencing children under the age of 5 years.  The definition and lengths of reported episodes of 
diarrhea also differed within the sample. The reported period of diarrhea episodes varied from 
diarrhea within the past 24 hours to the last diarrhea episode.  
2.3.2 ORT prescriptions during management of childhood diarrhea 
Before publication of 2004 WHO Guidelines. A majority of the findings of studies published 
before 2004 (5 out of 7) reported healthcare providers’ prescriptions of any ORT tended to be 
higher than 50% .12-17 Depending on the sample sizes of these studies, percentages of any ORT 
prescribed to children ranged between 60 % to 94.6% .15,18 Rarely did the studies report the 
prescription of ORT alone.  The highest percentage of ORT prescriptions were reported when 
prescribed in combination with other medications, mainly antibiotics. Only three studies 
mentioned ORT formulation recommended by the WHO.  
Medical doctors were reported to prescribe higher rates of any ORT compared to 
pharmacists.12-14,17  For example, Raghu and colleagues (1995) evaluated the awareness and 
attitude of medical doctors and pharmacists in India toward oral rehydration therapy for the 
treatment of diarrhea in children within a survey study and found that 77% (n = 53) of medical 
doctors reported prescribing ORT compared to 59% of pharmacists who declared prescribing 
ORT.14 The authors also reported that only one pharmacist in the study prescribed ORT using the 
WHO recommended formulation compared to 48% of pharmacists who prescribed ORT 
formulations that were not compliant with the WHO recommendation.14  
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After publication of the 2004 WHO guideline. More variability in ORT prescription rates was 
noted in studies published after the 2004 WHO guideline on the management of childhood 
diarrhea.19-22 Depending on the study design, sample population and sample size, ORT 
prescription rates varied between 2.4 % and 100%.22,23 In a prospective observational study 
auditing the prescriptions rates of doctors treating children between the age of 6 months and 5 
years in an Indian tertiary care hospital, ORT and zinc were reported to be prescribed in 
accordance with the 2004 WHO protocol in all cases of children suffering from diarrhea.23 
However, the authors also reported that among the 402 children who were prescribed additional 
medications for the treatment of diarrhea, deviation from the WHO protocol was noted in 78.4% 
of the cases.23 In other words, more than two thirds of the children who were treated by medical 
doctors, were prescribed additional medications not recommended by the WHO guideline during 
the management of the child’s diarrheal episode.  
Similar to the studies published before 2004, studies examining the practices of 
pharmacists with formal and informal training tended to report lower rates of ORT prescriptions 
then what was recommended by WHO guidelines.14,22 Diwan and colleagues used a simulated 
client survey to assess the treatment of childhood diarrhea in private pharmacies in the province 
of Madhya Pradesh, India.22 Of the 164 private pharmacists surveyed using a questionnaire with 
a simulation of a visit with a child suffering from diarrhea and their caregiver, only four 
prescribed ORT.22 Antibiotics, however, were prescribed by 40.24% (n = 66) pharmacies and 
anti-motility drugs were prescribed by 31.1% (n = 51) of pharmacists.22 It was also noted that 
ORT is cheaper and thus less, profitable for pharmacists to prescribe. 
Several other studies also reported on the significant number of prescriptions of other 
medications mainly antibiotics, anti-motility and probiotics drugs for the treatment of diarrheal 
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episodes. The WHO guideline has been published for more than a decade, yet, findings from the 
most recent study included in this review (published in 2016) indicate that antibiotics were 
unnecessarily prescribed in 12.2% of the cases and probiotics were prescribed in 78.1% of the 
cases of children with diarrhea (n = ,406).23 
2.4 Discussion 
The findings of the present study indicate that numerous observational studies have 
reported on healthcare providers’ management of childhood diarrhea. However, prescription 
rates varied significantly across the selected studies based on the population, study’s method and 
design as well as the type of data collected.  
A systematic review of the selected studies suggest that ORT was mainly prescribed in 
conjunction with other drugs. ORT was seldom prescribe alone and was not the first-line of 
intervention. In addition, the findings also indicated more variability in ORT prescription 
practices in the management of childhood diarrhea in the studies published after 2004 compared 
to those published before the 2004 WHO guideline. The overall limited rate of ORT prescription 
and wide disparity in ORT coverage was associated with healthcare professional training. 
Consistently pharmacists and/or pharmacy personnel were reported to prescribe lower rates of 
ORT compared to medical doctors and/or health facilities workers.  
These findings are consistent with a previous review on childhood diarrhea treatment 
coverage at the global and regional level.24 These authors stated that following the success of 
diarrhea management focusing on ORT usage in the 1990’s, the adherence to the 2004 WHO 
guidelines on the management of childhood diarrhea has been “extremely slow” and even 
“stagnant”.24 Low use of ORT has been associated with certain factors such as healthcare 
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providers’ knowledge and perception of the severity of the diarrhea episode, parents’ expectation 
and the financial profit to sell more expensive therapies.25 Each of the factors has been reported 
to influence the use of ORT and increase prescription of antibiotics and other drugs. Efforts must 
be made to improve national policies encouraging healthcare providers’ education, increasing 
community awareness, large scale manufacturing, and increase awareness and demand for ORT 
in the treatment of childhood diarrhea.  
2.4.1 Limitations 
Given the variability of the study designs, methodology, and population, findings from 
the studies could not be combined and extrapolated. This is indicative of the lack of consistency 
in research methodology of published studies. While mentioned in three studies, the review did 
not include research evaluating the care provided by traditional healers or community health 
workers, who play significant roles within communities in this region of the world. However, a 
systematic review reveals trends in ORT prescription that are consistent with previously 
published reviews and with the United Nation’s current published data.  
2.4.2 Implication for research 
A significant amount of evidence exists on the cost-effectiveness of ORT in diarrhea 
control programs, the findings suggest the need for more studies evaluating the actual prescribing 
behaviors of health providers during management of childhood diarrhea. This type of evaluation 
will offer important insight on the effectiveness and sustainability of already existing programs 
as well as identifying local and regional issues and barriers hindering the prescription of ORT by 
health providers in South Asia. This integrative review uncovers the need for observational 
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studies using more rigorous and standardized methodology to evaluate the overall prescription 
rates of ORT in the management of childhood diarrhea in South Asia.  
While the WHO guideline has been used to formulate national policies, the studies 
suggest the need to evaluate healthcare providers’ education and adherence to the WHO 
guideline and impact of the unnecessary use of antibiotics. Since prescription of the known 
strategies have been stagnant for the past 40 years, it is evident that the current training programs 
should incorporate a more sustainable message. These health education strategies must address 
the cultural norms of a given community and include ongoing re-assessment and education 
sessions. 
2.5 Conclusion 
With one of the highest rates of childhood diarrhea worldwide, South Asia remains the 
region of the world with the second lowest usage of ORT. While the evidence from a meta-
analysis cannot be combined, a systematic review of the selected articles reveals a trend that is 
consistent with already existing data in other regions of the world. Despite the publication of the 
2004 WHO guideline and the strong published research evidence on the cost effectiveness of 
ORT, observational study findings indicate that ORT is prescribed in low rates and inconsistently 
by medical doctors and pharmacists with formal and informal training. Allocating more 
investment in studies with stronger methodology will allow a more accurate evaluation of the 
medical doctors and pharmacists prescriptions of ORT in the management of childhood diarrhea.  
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Figure 1. Studies Selection Process 
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Table 1. Characteristics of Included Studies 
Authors/ Year/ 
Country 
Study design, study 
objectives 
Study population/ 
Number of 
participants 
Intervention Use of 
WHO 
guidelines 
Proportion of ORT 
prescriptions 
Proportion of 
prescription of 
therapies other 
than ORT 
Gani et al., 1991. 
Indonesia 
Design not specified 
To investigate both 
reported and observed 
prescribing practices 
for treatment of acute 
diarrhea in children 
under 5 years of age 
122 physicians 
participated in survey 
73 physicians 
participated in 
observational study 
Survey interview, 
observations of 
physicians' clinical 
practices and an 
in- depth 
interview.  
None ORT prescriptions 
by physicians :70% 
reported 
67% observed 
physicians 
Antibiotics 
prescriptions by 
physicians:  
61% of physicians 
94% of observed 
physicians 
Kasi et al., 1995. 
Pakistan 
Design not specified 
To screen the practices 
of a small sample of 
doctors confronted 
with children with 
diarrhea 
30 doctors Each survey team 
member 
introduced herself 
as the mother of 
the infant, and 
stated only that 
the child had 
diarrhoea.  
None Prescription of 
ORT by doctors: 
60% 
Mixture of kaolin 
and pectin: 46%  
Other drugs: 80% 
Raghu et al., 1995. 
India 
Design not specified 
To evaluate the 
awareness and practice 
of oral rehydration 
therapy amongst 
mothers, medical 
practitioners and 
pharmacists.  
48 medical 
practitioners, 56 
pharmacists and 55 
mothers of children 
with diarrhoea  
Interviews using a 
prepared 
questionnaire 
WHO ORT prescriptions: 
by pharmacists: 
WHO formulation 
(n = 1; 1.7%); non-
WHO formulation 
(n = 27;     % = 
48%).                                         
By doctors: WHO 
formulation (n = 8; 
%16.5); Non Who 
formulation (n = 
29;     % = 60.5) 
 
Nizami et al., 1996. 
Pakistan 
Design and objective 
not clearly stated 
996 children with 
diarrhea 
Observation of 
encounters 
between children 
with diarrhea and 
general 
practitioners (n = 
62) and 
pediatricians (n = 
28) 
None ORT prescription 
per qualification: 
general 
practitioners: 
53.2%; 
pediatricians: 
60.7%  
Antibacterials: 
50% of 
pediatricians 
Antidiarrhoeals: 
60% general 
practitioners and 
28% pediatricians 
Antiamoebic: 39% 
of general 
practitioners,32% 
of pediatricians 
Buch & Bashir, 
1997. India 
Design not specified 
To focus on the 
inadequacies in the 
current management 
practices of acute 
diarrhea  
1030 infants with 
acute diarrhea  
Information 
regarding nature 
of diarrhea and its 
management were 
collected from the 
details mentioned 
in the prescriptions 
of the infants 
None ORT/SSS 
prescriptions: 
4.1% of infants 
treated at private 
clinics and health 
units 
Antidiarrheal + 
antispasmodic 
drugs: 46.8% of 
infants treated at 
private clinic or 
health units 
Parenteral 
antibiotics: 11.3% 
of infants 
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Choudry et al., 
1997. Pakistan 
Survey 
To study the current 
practices and factors 
affecting the 
management of acute 
watery diarrhea  in 
children below 5 years 
of age 
262 general 
physicians 
Physicians were 
interviewed at 
their place of work 
by a team of three 
physicians using a 
pretested, semi-
structured 
questionnaire 
Yes ORT alone by 
physicians: 19%.             
ORT + drugs: 61% 
Prescriptions of 
drugs alone: 15% 
Howteerakul et al., 
2003. Thailand 
Design not specified 
To explore Thai 
physicians’ rationales 
about their prescribing 
practices for treating 
childhood diarrhoea 
424 cases of child 
diarrhea 
A clinical audit and 
observations of 
424 cases treated 
by 38 physicians 
used to estimate 
the prevalence of 
sub-optimal 
prescribing 
practices.  
Yes ORT prescriptions: 
91.3% of child 
cases                          
Antimicrobial: 
75.5% of child 
cases 
Antiemectics + 
Antispasmodic: 
32.4% of child 
cases 
ORT+ other 
drugs/IV:94.6%  f 
child cases                    
Ahmed et al., 
2009. India 
Cross sectional survey 
To study the treatment 
practices of diarrhea 
and symptoms at 
health facilities 
(medical practitioners) 
1052 children under 
5  
Household survey 
visits were 
conducted at the 
end of each season 
and details 
regarding any 
current episode of 
diarrhea and any 
past episodes of 
diarrhea were 
recorded from the 
mother 
None ORT only: 8.7% of 
children treated at 
the health 
facilities 
Antibiotics: 77.9% 
of children treated 
at health facilities 
Saengcharoena et 
al., 2010. Thailand 
Simulated client survey 
To compare practice 
behavior and attitudes 
of pharmacy personnel 
in the management of 
childhood diarrhea 
63 Pharmacists simulated client 
survey and 
questionnaire 
survey 
None ORT prescriptions: 
4.2% of 
pharmacists  
Antibiotics: 25.2% 
of pharmacists 
Chakraborti et al., 
2011. India 
Design not specified 
To determine the 
prescribing practices of 
doctors in 
management of acute 
diarrhea in children.  
388 children suffering 
from acute diarrhea  
Not specified IAP 
guideline 
ORT prescriptions 
by doctors:  90.2%  
Antibiotics: 82.5% 
Pro/prebiotics: 
56.4% 
Antiemectics: 43% 
Pathak et al., 2011. 
India 
Prescriptions chart 
review 
To determine the levels 
of adherence to 
treatment guidelines 
for acute diarrhea in 
children up to 12 years 
seen in drug 
prescriptions  
843 prescriptions Pharmacy 
assistants and 
medical officers 
assisted in the 
collection of 
information from 
outpatient 
prescriptions  
None ORT alone:  58% 
of reviewed 
prescriptions  
Antibiotics: 71% of 
reviewed 
prescriptions 
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Aung et al., 2013. 
Myannmar 
Survey study 
To determine the 
norms for both home-
based care and health- 
seeking behavior 
253 children under 5 A structured 
questionnaire was 
administered by 
trained healthcare 
workers. 
Yes Any ORT:  
Government 
health facilities: 
16.6% of infants 
Private providers: 
13.4% 
Pharmacy: 0.8% 
 
Pham et al., 2013. 
Vietnam 
Pre intervention 
survey. 
To report knowledge 
and practice of staff in 
pharmacy settings 
regarding management 
of childhood diarrhea 
220 pharmacies            
281 pharmacy staff  
survey was used to 
record knowledge 
and reported 
practice  and 
simulated client 
surveys 
None Any ORT 
prescriptions: 
41.9% of 
pharmacists and 
pharmacy staff 
Antibiotics: 14.8% 
of pharmacists 
and pharmacy 
staff 
Kanungo et al., 
2014. India 
Cross-sectional study 
using interviews 
To asses diarrhea- 
related knowledge, 
practice, their 
correlates and 
interrelationship 
among allopathic 
practitioners treating 
diarrhea patients in the 
slums of Kolkata 
264 practitioners Interviews 
collected on 
practitioners' 
knowledge 
attachment, year 
of practice, 
average age 
None Prescription of 
ORT: Odds Ratio = 
1.24 of qualified 
and government 
physicians 
Antibiotics: 
49.24% of 
physicians 
Naeem et al., 
2014. Pakistan  
Cross-sectional survey 
To appraise 
general  practitioners i
n the management 
of  acute 
watery diarrhea for 
children under 5 years 
of age 
380 general 
practitioners 
Semi structured 
questionnaires 
assessing the 
knowledge and 
practices regarding 
the management 
of acute watery 
diarrhea  
Yes  Prescription ORT 
based on general 
practitioners’ 
qualification: 
MBBS only 48.1%.  
MBBS and Minor 
diploma 
pediatrics: 100% 
Antidiarrheal 
drugs: MBBS 
74.4% 
MBBS + minor 
diploma in 
pediatrics: 100% 
Diwan et al., 2015. 
India 
Cross-sectional study 
using simulated client 
survey 
To assess the 
treatment of childhood 
diarrhea in private 
pharmacies  
164 private 
pharmacies 
Four simulated 
clients visited the 
pharmacies and 
filled out a 
questionnaire 
within 15 minutes 
after leaving the 
pharmacy. 
Yes ORT prescribed: 
2.44% pharmacies 
Antibiotics: 
40.24% by 
pharmacies 
Anti-motility drug: 
31.1% by 
pharmacies 
 
De et al., 2016. 
India 
Prospective 
observation: Audit of 
prescriptions 
To study the 
prescription practices, 
regarding adherence to 
WHO protocol and 
deviations in the 
management of acute 
diarrhea in children 
402 children 6 
months- 5 years with 
acute diarrhea 
episode 
Cases were 
evaluated in detail 
for clinical history, 
physical 
examination, 
prescription given 
by treating doctor 
at the hospital and 
associated co-
morbidity. Each 
prescription was 
scrutinized to 
Yes ORT: 100% of 
cases 
Probiotics: 78.1% 
of the cases 
Antibiotics: 12.2% 
of the cases 
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determine 
whether WHO 
protocol was 
followed or not 
Fisher Walker et a., 
2016. India 
Survey using: Interview 
and direct observation 
To characterize the 
childhood diarrhea 
treatment knowledge 
and practice of both 
formal and informal 
private sector 
providers  
232 private providers Interviews and 
direct observation 
conducted on 
diarrhea treatment 
knowledge and 
practice and access 
to ORS and zinc 
supplies 
Yes Interviews: ORT 
prescription: 
68.1% 
 Direct 
observations:ORT 
prescriptions: 
56.7%  
Antibiotics: 65.9% 
 Zinc: 35.8%.             
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What is known: 
Even in the developed country like the United States, diarrhea associated infections remain a 
health issue in infancy and early childhood. Breastfeeding during the first 6 months after birth 
has been proven to provide optimal immunity to prevent diarrheal infections.  
What this study adds:  
Breastfeeding cessation prior to six months of age significantly increases the risk of having a 
diarrheal episode prior to one year of age by 31-48% according to a US database.   
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Abstract 
Background: Diarrhea diseases remain a major cause of childhood morbidity in the United 
States. Optimal breastfeeding has been identified as one of the most effective measure to prevent 
diarrhea diseases in childhood.  
Objective: To evaluate the impact of breastfeeding duration during the first 6 months of age on 
the incidence of diarrhea in infants between 7 and 12 months in the United States. 
Methods: A secondary data analysis was performed using mothers and infants participating in 
the Infant Feeding Practices Study II (2005-2007).  
Results: Compared to those who breastfed for 6 months or more, infants who discontinued 
breastfeeding between 0 and 3 months were at 48.4% greater risk to have diarrhea at 7 and 12 
months and those who discontinued breastfeeding between 3 and 6 months were at 31% greater 
risk of having diarrhea between 7 and 12 months. 
Conclusion: Breastfeeding cessation before the first 6 months is a significant predictor of 
diarrhea between 7 and 12 months.  
 
Word count: 2989 
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3.1 Introduction 
The major burden of diarrheal related morbidity and mortality is reported to be in the 
developing regions of the world. However, children living in richer countries are also affected by 
diarrheal diseases.4 While accounting for fewer deaths in developed countries, diarrheal 
infections are associated with high rates of doctors and emergency hospital visits, hospital 
admissions and medical costs. In the US, diarrheal related infections account for approximately 
300 deaths each year in children under the age of 5.4  
Causing approximately 200, 000 hospitalizations, it is estimated that diarrhea cost about 
$250 million in direct medical expenses each year.4-5 Low birth weight, being male and black are 
all factors that have been found to significantly increase the risks of dying from diarrheal 
diseases in the US.6 Preventive measures to control and reduce the impact of diarrhea in the US 
includes the promotion of rotavirus vaccines and optimal breastfeeding for the first 6 months of 
life are among the key strategies to prevent diarrhea.5 
Before the introduction of rotavirus vaccines, the pathogen was reported to cause the 
most frequent episodes of diarrhea in US children with 55,000 to 70,000 hospital admissions 
each year and approximately $1 billion to the US government in medical cost.7  Following its 
introduction between 2007 and 2009, the rotavirus vaccine was estimated to reduce 
gastroenteritis hospitalizations by at least 53% in US infants living in the Western part of the 
country.7 The vaccine reduced by more than 70% diarrheal related infections among children 
between 1 to 4 years old in the Southern, Northeastern and Midwest regions of the US.7 Besides 
the rotavirus vaccine, the promotion of breastfeeding for the first 6 months of life has been 
another cost-effective preventive measure against diarrheal diseases in the US.  
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Since 1984, breastfeeding was identified as one of the most important and cost-effective 
intervention, significantly reducing the incidence of infectious diseases among children 
worldwide, especially diarrhea and pneumonia.4-6 Human breastmilk contains bioactive 
molecules mostly secretory antibodies, lactoferrin and glycans offering protection and 
maturation of the gastrointestinal track and immune system during infancy and early childhood.7-
8 However, the 2014 CDC report card on breastfeeding indicates that only 18.8% of US infants 
are exclusively breastfed at 6 months while 49.4% receive some breastmilk through 6 months.9 
These numbers depict the perpetuation of suboptimal breastfeeding in the US since they remain 
far from the Healthy People 2020 objectives of 25.5% exclusive breastfeeding at 6 months and 
60.6% infants receiving some breastmilk at 6 months.9-11 
In the most recent meta-analysis on breastfeeding practices published in the Lancet, it 
was reported that compared to middle-income and low-income countries, the prevalence of any 
breastfeeding at 12 months is lower in high-income countries.17 The weighted prevalence of 
breastfeeding at 6 months in high income countries was approximately 45% (compared to more 
than 95% in low income countries) and was 20% at 12 months (compared to more than 90% in 
low income countries).17 Breastfeeding practices among US mothers are not an exception. The 
prevalence of any breastfeeding at 12 months in the US is around 27%.17  
While the protective effect of breast milk is undeniable, significant gaps still exist in the 
promotion and practice of early breastfeeding initiation and continuation for the first 6 months of 
life, even in countries like the US. Non-exclusive or early interruption of breastfeeding, also 
known as suboptimal breastfeeding, was ranked in 2010 by the Global Burden of Disease Study 
as the second leading risk factor of disease burden in children under the age of 5 worldwide 
regardless of whether the child was in a developed or under-developed country.18 
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The prevention of persistent diarrhea through the promotion of optimal breastfeeding is 
imperative in reducing the burden of the symptom in early infancy and childhood. Thus 
providing more evidence on the outcomes related to the immunologic properties of breastfeeding 
using a national survey database, will strengthen the empirical evidence and encourage the 
promotion of optimal breastfeeding practices of US mothers. The Infant Feeding Practice Survey 
II (IFPS II) dataset was utilized as it is the most recent survey that compiled comprehensive 
information on US mothers and infant feeding practices and their associated health status.12 By 
our best knowledge, this is the first study to examine the IFPS II data to assess the longitudinal 
effect of breastfeeding duration on the occurrence of diarrhea.13  
The goal of this study was to evaluate the impact of breastfeeding duration during the 
first 6 months after birth, on the maternal reports of diarrhea episodes in infants during their first 
year of life. You could add research questions/hypotheses here.  A secondary data analysis was 
performed to answer the following research question: Is the incidence of diarrhea episodes in 
infants between the ages of 7 to 12 months influenced by mothers' breastfeeding duration 
between 0 to 6 months? The research question was based on the hypothesis that compared to 
infants who discontinued breastfeeding between 0 and 6 months, the infants who were breastfed 
up to 6 months or longer would have a lower count of diarrheal episodes, reported by mothers 
within 2 weeks prior to completion of questionnaires at 7, 9, 10, and 12 months. 
3.2 Patients and Methods 
A secondary data analysis method was used to in evaluate the effect of breastfeeding 
duration during the first 6 months of life on the reported incidence of diarrhea in infants between 
the ages of 7 and 12 months. The study population included mothers and their infants enrolled in 
the IFPS II. Longitudinal data was collected between May 2005 and June 2007 on a nationwide 
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consumer opinion panel of 4902 women who were at least 18 years old, in their third trimester of 
pregnancy and expecting a singleton birth.12  
Mothers were excluded from the study if: they refused to participate; did not return the 
questionnaire; the infant was born before 36 weeks gestational age; the infant was born with a 
long-term illness. Mothers were also excluded from the original study if they resided in areas 
where the United States Postal Service could not deliver mail after the 2005 Gulf Coast 
hurricanes.12 Based on these exclusion criteria, a total of 3033 mothers completed all the survey 
questionnaires.12 
3.2.1 Participants 
The sample size was limited to mothers who completed the questionnaires with reports 
on breastfeeding cessation, last time a questionnaire was retuned and diarrhea episodes between 
7 and 12 months after delivery. We excluded data missing study variables (no survey responses 
reported) on the study’s variables. A total sample of 2344 dyads (mother/infant) were included in 
the final analysis (Figure 1).  
3.2.2 Study variables 
Breastfeeding duration. Breastfeeding duration was the primary exposure variable and 
corresponds to the infant’s age when the mother reported to completely discontinue 
breastfeeding and provision of expressed breastmilk. The variable indicates the infant’s age 
when he/she stopped receiving breastmilk either directly from the breast or expressed (pumped). 
The variable was categorized into four subset variables: 1) infants reported to have never 
breastfed (bfduratn= 0); 2) infants who stopped receiving breast milk between 0 and 3 months 
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(0.1 to 12.0 weeks); 3) infants who stopped receiving breast milk between 3 and 6 months (12.1 
to 23 weeks); and 4) infants who receiving breast milk at 6 month or beyond (≥ 24 weeks?).  
A variable, last questionnaire received, was created to identify the number of mothers 
who dropped out before the 6 month study period. The last questionnaire received was coded the 
last time (in month), mothers were reported to return an IFPS II questionnaire. The code allowed 
estimation of the number of mothers who discontinued breastfeeding between 0 and 6 months 
after delivery. This variable was also used to estimate the sample size of each breastfeeding 
duration groups.   
Reported episodes of diarrhea. The main outcome variable was reported diarrheal episodes 
within the 2 weeks prior to receiving the questionnaire at 7, 9, 10 and 12 month of infant age. 
Data on infants’ diarrheal episodes were obtained on the questionnaire by asking the following 
question: “Which of the following problems did your baby have during the past 2 weeks?” 
Diarrhea was listed as one of the multiple choice options including fever, vomiting and ear 
infection. The occurrence of a diarrheal episode was defined as a mother reporting at least one 
episode of diarrhea within the 2 weeks prior to receiving questionnaires in months 7, 9, 10 and 
12. For the purpose of the analysis, the dependent variable (reported episodes of diarrhea) was 
recoded into a binary variable: 0 = no episodes of diarrhea; 1 = 1 or more episodes of diarrhea 
reported at months 7, 9, 10 and 12.  
A total of 59 mothers did not respond to the question on diarrhea at least once between 
months 7 and 12 month questionnaires. A sensitivity analysis was completed to determine 
whether treating the lack of response as occurrence (condition 1) or non-occurrence (condition 2) 
of diarrhea would modify the study finding. No statistically significant difference were found. 
The statistical analysis was completed using the more conservative condition, condition 1. 
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Offset variable. The number of times a mother reported an episode of diarrhea between 7 and 12 
months depended on the number of questionnaires she returned during that given period. 
Therefore, the number of questionnaires returned by each mother could affect the total count of 
reported diarrhea episodes. For this reason a variable “number of questionnaire returned” was 
created to account for the total number of time mothers returned the survey questionnaire 
between 7 and 12 months. A value from 0 to 4 was given based on the number of times a mother 
returned a postnatal questionnaire at months 7, 9, 10 and 12. This variable was considered an 
offset variable and was used as a control variable during statistical analysis using Poisson 
regression.   
Other variables. Following consultation with a certified lactation specialist and an extensive 
literature review, a series of mother and infant characteristics were identified as potential 
confounders were therefore controlled for in the Poisson regression.  The variables included 
sociodemographic characteristics of the mothers such as age, race, level of education and 
employment status. Infant characteristics included gender, weight and occurrence/non-
occurrence of infant breastfeeding during the neonatal period. 
3.2.3 Statistical Analysis 
Frequency and descriptive statistics were completed for the demographic characteristics 
of the sample using SPSS version 22.14 To assess the association between breastfeeding cessation 
and the report of diarrhea episodes in a longitudinal manner, generalized linear modeling using 
Poisson regression was used. Recoding of the variables of interest was completed using SAS 
version 9.4.13  
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Diarrhea episodes were self-reported by the participating mothers and returns of the 
questionnaires occurred at different times for each participants; so these variables could not be 
controlled. For these reasons, rate ratios rather than relative risk were conducted to estimate the 
possible relationship between the independent and dependent variables. Poisson regression was 
applied to estimate the rate ratio (RR) and a p value was obtained based on the Wald test and 
95% confidence interval of the reported occurrence of diarrhea between months 7 and 12 as it 
related to breastfeeding cessation between 0 and 6 months. All analyses were completed using 
SPSS version 22.15  
3.3 Results 
3.3.1 Participants’ demographics 
Demographic statistics for maternal and infant characteristics are presented in Table 1. In 
the infant cohort, the male to female ratio was almost equal with 49.7% male and 50.2% female. 
A majority of the infants were delivered vaginally (71.3%) with an average birth weight of 7.64 
pounds. Descriptive analysis of the maternal participants indicated that mothers’ average age was 
29 years old with the majority being White (85.5%) and married (77.4%). Most mothers were 
highly educated (65% had some college education) and 45% lived in a household with an income 
level higher than $50,000. Maternal and infant characteristics in this cohort mirror the larger 
IFPS II sample of 3033 mother- infant dyads. A majority of the mothers in the initial IFPS II 
study were White (84.4%), between 25 to 34 years old (61.4%) with a college education 
(40.2%).12 
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3.3.2 Breastfeeding duration and reported episodes of diarrhea 
Of the 2344 mothers included in this study, 84.3% (n= 2000) either breastfed or tried 
breastfeeding their infant during the neonatal period. More than a quarter of the infants (25.8%) 
stopped receiving any breastmilk before 3 months. In this study, 14.2% of the infants were never 
breastfed either directly from the breast or expressed breastmilk from the bottle; while 38.5% 
stopped being breastfed between 0 and 6 months. A total of 1109 (47.3%) infants were 
reportedly breastfed for the first 6 months or more. Approximately 28% of the mothers reported 
one or more episodes of diarrhea within the last 2 weeks after receiving questionnaires in months 
7, 9, 10 and 12. The reported episodes of diarrhea increased over time with 6.4% mothers 
reporting at least one episode at 7 months compared to 12% reported at least one episode at 12 
months. 
The incidence of diarrhea for infants who breastfed for 6 months or more was 
approximately 93 per 1000 infants (p = 0.000). The results from the Poisson regression model 
that assessed the relationship between the four-level breastfeeding cessation variable and 
reported episodes of diarrhea are described in Table 2. Repetition of the analysis using either 
condition 1 (considering “no answer on diarrhea occurrence question” as no occurrence of 
diarrhea) or condition 2 (considering “no answer on diarrhea occurrence question” as occurrence 
of diarrhea) did not change the rate ratio for breastfeeding cessation. Further analyses were 
completed using the more conservative approach, condition 1. 
Breastfeeding cessation during the first 6 months of life is a significant factor predicting 
the number of reported episodes of diarrhea between 7 and 12 months. Compared to the infants 
who breastfed for 6 months or more, infants who discontinued breastfeeding between 0 and 3 
months were at 48.4% greater percentage to have a reported episode of diarrhea at least once 
 
 
47 
 
between 7 and 12 months (p = 0.000 CI [1.18- 1.71]). Infants who stopped receiving any 
breastmilk between 3 and 6 months were at 31.1% greater risk of having a diarrhea episode 
reported by their mother between 7 and 12 months (p = 0.016, CI [1.17- 1.90]) compared to 
those who breastfed for 6 months or more.  
When adjusting for the demographic variables by entering them as covariates in the 
Poisson regression modeling, the results indicate three maternal characteristics significantly 
affected reported episodes of diarrhea. These variables were household income, maternal age, 
and maternal education level. Among the mothers who breastfed their infants, every $1,000 
increase in their household income was linked to a 2% decrease in reported episodes of diarrhea 
at months 7, 9, 10 and 12 (p = 0.006).  The results also showed that reported episodes of diarrhea 
decreased with older (RR = .98; p = 0.000) and more educated (RR= .92; p = 0.02) mothers 
(Table 2).  
In addition, none of the reported infant demographic characteristics were found to 
significantly influence the reported episodes of diarrhea between 7 and 12 months. When infant 
birth weight was added as a covariate in the regression model, the estimate rate ratio was .970 (p 
= .367). Gender or delivery method also did not show a statistical significant impact on the 
relationship between breastfeeding duration and report of diarrhea episodes (p = .143 and p= 
.684 respectively). In other words, inclusion or exclusion of the infants’ demographic variables 
in the regression model did not change the rate ratio estimates of reported episodes of diarrhea 
between 7 and 12 months based on breastfeeding duration before the age of 6 months. 
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3.4 Discussion 
Breastfeeding is considered the most cost effective intervention to assist in preventing 
diarrhea in early infancy and childhood. In a 2011 meta-analysis of studies performed in 
developing countries between 1980 and 2009, Lamberti et al., reported that no breastfeeding 
increased by 26% the risk of incidence of diarrhea in infants between the ages 0 to 5 months.16 
While exclusive breastfeeding is the recommended practice for infants up to 6 months of age, the 
authors reported that any breastfeeding for more than 6 months had a protective effect on 
outcomes such as diarrhea. Increasing evidence indicates that antibodies and glycobiome found 
in breastmilk provide an important source of protection against infectious diseases.15 These 
breastmilk components are reported to provide protection against diarrhea by decreasing the 
incidence and duration of diarrheal episodes.16 
Consistent with the previous research, the present study demonstrates that breastfeeding 
for 6 months or more could significantly decrease the incidence of diarrhea for infants younger 
than 12 months. The results of the secondary data analysis indicated that approximately 93 in 
1000 infants who breastfed for 6 months or more had at least one episode of diarrhea reported by 
their mothers between 7 and 12 months. The number of infants experiencing an episode of 
diarrhea increased by 48.4% if they stopped receiving breastmilk before 3 months and by 31.1% 
if they stopped receiving any breastmilk between the first 3 to 6 months of life. The findings 
showed that infants who breastfed for less than 3 months had the highest risk of diarrhea prior to 
12 months of age.  
This could be due to the decrease in breastfeeding intensity and introduction of solid 
foods. In a previous secondary analysis of the IFPSII, Grummer-Strawnn et al. (2008) reported 
that by 3 months, majority of the infants (80%) were either fed breastmilk or formula milk. By 4 
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and 5 months, 61% of the infants were fed with formula.36 Supplementation and early 
introduction of food other than breastmilk have been linked with suboptimal breastfeed and 
increase likelihood of infections like diarrhea- related diseases.14  
When adjusting for mothers’ age, education and household income, breastfeeding 
duration was significantly associated with reported episodes of diarrhea. Adding each of these 
variables individually in the regression model was associated with variation in the event of 
having a reported episode of diarrhea varied statistically significantly. Higher income households 
decreased the likelihood of reporting an episode of diarrhea by 2%. Infants whose mothers had a 
higher level of education decreased the risk of reporting an episode of diarrhea by 8%. These 
results are consistent with previous research and publications reporting that higher income and 
more educated mothers tend to breastfeed longer and thus, have healthier infants with less risks 
of diarrheal symptoms.37-40   
Jones et al, assessed the factors associated with breastfeeding practices in US infants 
using the 2007 National Survey of Children’s Health. The authors reported that children living in 
families with a household poverty status between 200% and 399% of the federal poverty level 
were 85% less likely to ever breastfeed compared to their counterparts living in household with a 
poverty level higher than 400% the federal poverty level.37 In addition, the authors also found 
that 20 years old or younger mothers are .88 times less likely to ever breastfeed compare to 30 
years old or older mothers.37 Results from Jones’ study and the present study reflect the 2011 
“Surgeon General’s Call to Action to Support Breastfeeding”, the US Department of Health and 
Human Services noted the significant disparities in breastfeeding based on race and ethnicity, 
socioeconomic characteristics and geographical location.41 
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This study is the first to explore a longitudinal relationship between breastfeeding 
duration and diarrhea episodes using the IFPSII dataset. The use of a more recent database to 
explore the protective effect of breastfeeding strengthens the literature and provides more 
evidence toward the promotion of breastfeeding in early infancy at the clinical practice and 
community level. 
3.4.1 Limitations 
While consistent with the current literature, the results are subject to certain limitations. 
Because the IFPS-II dataset is derived from a self-selected costumer opinion panel rather than 
random sampling, it is not a necessarily representative sample of the US population. 
Participating mothers were predominantly white, medium to high income with higher level of 
education. Therefore, the study findings cannot be generalized to the entire US population.  
Second, breastfeeding cessation was a composite variable that did not distinguish 
between infants who exclusively breastfed and those who partially breastfed. Had these items 
been available in more precise variables it may would have allowed the formulation of a stronger 
relationship between exclusive breastfeeding duration and the occurrence of diarrhea. More 
specific information on the breastfeeding type may have also allowed for exploration in the 
differences between the effects of exclusive versus any breastfeeding duration on reported onset 
of diarrhea episodes.  
Thirdly, the code 77, which represented both mothers who dropped out during the study 
and those who continued breastfeeding beyond the study period, did not allow a clear distinction 
between the mothers who dropped out early during the study and when did they drop out versus 
the mothers who continued breastfeeding beyond the 12 months study period. Finally, the lack of 
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data collected between the neonatal period and month 3 was a missed opportunity to depict a 
clearer picture of early breastfeeding cessation and potential influencing factors. Additionally, 
the reported episodes of diarrhea were self-reported by the mothers, so the definition of diarrhea 
might have varied based on mothers’ knowledge and perception.  
3.4.2 Implication for practice and research 
The study’s findings support US and WHO clinical practice guidelines regarding 
breastfeeding during infancy. The results also highlight the issue of suboptimal breastfeeding 
during the first 6 months of life and its impact on the increased incidence of diarrhea later during 
the first year of life. By providing statistically significant evidence in the protective effect of 
breastfeeding duration for 6 months or more, the study adds to the existing research and 
evidence-based policies for the promotion of optimal breastfeeding at the clinical and community 
level.  
While already established and practiced, these strategies need to be re-evaluated to 
identify and address the factors influencing limited adherence to optimal breastfeeding during 
this critical period in infancy. The study sample did not include additional minority groups. 
Therefore, further studies using a prospective longitudinal design must be done to better capture 
breastfeeding cessation and diarrhea incidence across a nationally representative sample thereby 
reflecting the racial/ethnic and economic diversity of the US population. 
3.5 Conclusion 
Diarrhea related infections remain an issue for children under the age of 5 years 
worldwide. Optimal breastfeeding for at least the first 6 months of life has been considered one 
of the most effective interventions for protecting infants against diarrhea. The findings from the 
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present secondary data analysis using a nationwide dataset provides more evidence for the 
protective effect of breastfeeding against diarrhea. While this has been well-known for the last 
three decades, adherence to optimal breastfeeding for the first 6 months of life remains limited, 
even in more developed countries like the US and within a subgroup of the population with 
higher income, education level and better access to healthcare services and support. Further 
research leading to evidence based health promotion programs are warranted to identify and 
address factors predicting early breastfeeding cessation. Additionally, these programs need to 
offer healthcare providers the means to detect early in the post-partum period (during 
hospitalization) and follow-up periods, mothers at-risk for suboptimal breastfeeding practices to 
offer the best protection against diarrhea illnesses.   
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Table 1 Maternal and Infants Demographics 
 Total N= 2344 (%) 
Mother’s Characteristics 
Race 
     White 
     Black 
     Asian/Pacific Islander 
    Other/Missing 
 
 
2003 (85.5) 
89 (3.8) 
64 (2.7) 
188 (8.0) 
Age (averaging years ) 
     18 - 28 
     29 - 39 
     40 or older 
 
1092 (46.5) 
1158 (49.4) 
94 (4.1) 
 
Marital status 
     Married 
     Unmarried 
   Missing 
 
1811 (77.3) 
402 (17.2)  
131 (5.6) 
Household Income (US dollars) 
     less than 5000 
     5000-24999 
     25000- 49999 
     50000-74999 
     75000-99999 
     100000 or over 
 
47 (2.0) 
428 (18.3) 
819 (34.9) 
591 (25.2) 
271 (11.6) 
188 (8.1) 
Education Level 
     High-school or less 
     Some college 
     College graduate or higher 
     Missing 
 
435 (18.6) 
827 (35.3) 
940 (40.1) 
142 (6.1) 
Employment status 
     Full time 
     Part time 
     Unemployed/missing 
 
864 (37) 
271 (11.6) 
1209 (52) 
Infant’s characteristics 
Sex 
     Male 
     Female 
 
1165 (49.7) 
1177 (50.2) 
Weight (average) 7.64 lbs 
Delivery method 
     Vaginal 
     Cesarean section 
 
1671 (71.3) 
673 (28.7) 
Ever breastfed or tried breastfeeding 
     Yes 
     No 
 
2000 (85.3) 
344 (14.7) 
 
 
 
 
56 
 
Table 2 Effect of breastfeeding duration before 6 months and other variables on reported 
episodes of diarrhea in months 7, 9, 10 and 12. 
Parameter Rate Ratio (RR) estimate for reported episode of diarrhea 
 RR (p value) 95% CI 
Intercept      0.093 (.000) [0.083-0.103] 
Breastfeeding cessation 
     Never breastfed 
     Breastfed between 0-3 months 
     Breastfed between 3-6 months 
           
 
1.24 (.043) 
  1.48 (.000) 
  1.31 (.016) 
 
[1.007 - 1.52] 
[1.26 - 1.74] 
[1.05 - 1.64] 
Household income .98 (.003) [.97 - .99] 
Mother’s age .98 (0.000) [.96 - .99] 
Education .92 (.02) [.86 – 0.99] 
 
Figure 1 Participants’ selection process 
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Figure 2 Percentage of reported number of diarrhea episodes at 7,9,10 and 12 months based on 
breastfeeding duration.
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Abstract 
Background: In limited resources countries, the diagnosis and management of diarrheal diseases 
are mainly symptom based. A pathogen identification tool suited to resources limited settings 
will enable accurate identification of diarrheagenic pathogens, thereby improving management 
of diarrhea.  
Method: This feasibility study aims to test the sensitivity of a point-of-care lateral flow assay 
strip under two different environmental conditions to mimic temperate compared to a hot climate 
to Specifically, the goal is to correctly detect potential diarrheagenic pathogens present in stool, 
such as Escherichia coli, under two different temperatures (69°F and 91°F). Time before the 
appearance of positive signals and color intensity of the signals at the test and control zones were 
used for sensitivity and performance analysis. 
Results:  In the presence of target DNA bound with gold nanoparticle and detection probe 
complex, interaction with the capture probe at the test zone produces a red signal observable by 
the naked eyes. At 69°F, optimum color intensity of the red signal was detected at 10 minutes 
with 10 and 25nM target DNA concentrations. At the 91°F, interaction with the capture probe at 
the test zone produced light pink signal observable by the naked eyes after the first 5 minutes. 
The signal was only observable at 10 and 25nM target DNA concentrations. Generalized linear 
model regression suggests that for every 1nM increase in target DNA concentration, color 
intensity of the signal decreased by 3.8% in pixel value.  
Conclusion: The tool was able to positively detect the presence of Escherichia coli at different 
concentrations in a 69°F environment. Further optimization may improve the tool’s sensitivity at 
91°F. This is a step forward in the utilization of a Point-of-Care pathogen identification tool to be 
reliable in resource-limited settings.  
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4.1 Introduction 
The diagnosis and management of diarrheal episodes are mainly based on physical 
symptoms. Laboratory diagnostic tests are expensive, time consuming, require significant 
training and are often not available in a timely way (Kotloff et al., 2013; Kaushik., 2016). The 
diagnosis and treatment of diarrheal diseases, based solely on patient or caregiver reported 
clinical symptoms, is often inaccurate, causes preventable medical complications and 
unnecessary use of other therapies such as broad spectrum antibiotics. In addition, inpatient 
hospitalization for unresolved diarrhea episode create a significant economic burden to the 
household and healthcare system. The average medical cost of hospitalization for a household is 
approximately $44 in Rwanda, $3 in India and $6 in Pakistan (Ngabo et al., 2016; Rheingans et 
al., 2012).  
Molecular diagnostic methods, mostly with polymerase chain reaction (PCR), are the 
current gold standard tests for diagnosis of infectious diseases (Platts-Mills et al., 2012). 
However, PCR equipment and reagents are expensive, require skilled personnel and are 
subjected to amplification bias (Platts-Mills et al., 2012; Sjöling et al., 2015). Reliable and valid 
diagnostics are fundamental to identify the causes of a disease, formulate appropriate treatment, 
limit unnecessary use of antibiotics and reduce the disease burden. There is currently, a growing 
interest to develop lateral flow assays (LFA) for Point-of-Care (POC) diagnostic tool relevant to 
the realities of limited resources settings (Reid, Fidler, & Cooke, 2013; Wang et al., 2016).  
These novel diagnostic platforms need to be developed to address the WHO seven 
characteristics of POC test for low resources settings. Also known under the acronyms 
ASSURED the POC tests must be affordable, sensitive, specific, user-friendly, rapid and robust, 
equipment-free and deliverable to end users (Mabey, Peeling, Ustianowski, & Perkins, 2004; 
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Dittrich et al., 2016).  
Given the recommendations of the ASSURED criteria, the present study is a feasibility 
study that aims to assess the sensitivity of a rapid, simple to use, diarrhea pathogen identification 
tool. Climate variation has been associated with an increase relative risk of diarrhea diseases by 
22-29%; mainly by adversely impacting the quality of water supply and increasing temperature 
and rainfall worldwide (Kolstad & Johansson., 2011; Mellor et al., 2016). It is estimated that for 
every 1 degree Celsius increase in temperature there is approximately a 7% increase in diarrhea 
(Carlton, Woster, DeWitt, Goldstein, & Levy, 2016).  
The tool was developed as a collaboration with the National Institutes of Health, National 
Institute of Nursing Research and GoDx Inc. It consists of a paper-based, colorimetric LFA strip, 
using nucleic acid detection. The aim of this feasibility study was to evaluate the ability of this 
tool to positively detect potential diarrheagenic pathogen under simulated environment such as 
hot temperatures. Since LFA are intended to be used in the field, in resources limited settings, 
the strips may be affected by the surrounding environmental conditions. In addition, increasing 
evidence suggests that environmental factor such as temperature, significantly affect the 
sensitivity of LFA (Choi, 2016). The successful completion of this study is expected to result in 
further optimization of a tool; allowing healthcare providers, to formulate better management of 
diarrhea by accurate identification of diarrheagenic pathogens regardless of the surrounding 
environmental condition. 
4.2 Methods 
4.2.1 Pathogen Identification Tool  
The tool was developed as a collaboration with the National Institutes of Health, National 
Institute of Nursing Research and GoDx Inc. It consists of a paper-based, colorimetric LFA strip, 
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using nucleic acid detection. Nucleic acid detection provides critical genetic information in 
detecting the presence of infectious pathogens, the diagnosis and treatment of genetic diseases 
and cancers (Sun, Xianyu, & Jiang, 2014). Paper has many natural properties making it adequate 
to use in resource-limited settings. The most important features include its ability to passively 
transport fluids through capillary flow; it is made of cellulose making it compatible with various 
biological samples; its white color allows contrast background for visible and colorimetric 
readouts; it is cheap, thin and light, hence easy to transport and store (Zhao, Brook, & Li, 2008). 
The major principle in LFA involves an interaction or hybridization of a single-stranded 
target DNA region of commercial Escherichia coli (E. coli) with complementary capture probe 
forming a double-stranded nucleic acid. The hybridization will produce a colorimetric signal and 
allowing the detection of the bacteria target DNA. Gold nanoparticles (AuNP) are used as 
colorimetric probes in the tool. The red predictable color change of AuNP aggregation provides a 
platform for colorimetric detection using AuNP as signal label to trace hybridization of the target 
DNA (Zhao, Ali, Aguirre, Brook, & Li, 2008). 
The LFA strip is about 6.0 cm long and is made of: a glass fiber sample pad, a conjugate 
pad loaded with gold nanoparticles and detection probe complex, a nitrocellulose membrane 
containing a test zone and a control zone and a cellulose absorbent pad facilitating fluid flow.  
Colorimetric responses at the test and control zones of the LFA strip indicates the presence of the 
target DNA diarrhea pathogens. More details on the tool are mentioned in another publication.  
4.2.2 Study procedure 
Commercial E. coli (2011C- 3911) DNA target sequence was purchased and cultured in 
100µl of broth to a final concentration of 100µM. Five different dilutions of the target DNA 
solution were made in 4X SSC buffer. They included: 1nM, 10nM, 25nM, 100nM and 200nM. 
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Six strips were used, each deposited with 85ul of the target DNA solution at each of the five 
aforementioned concentrations.  A strip deposited with a solution containing 0nM target DNA 
was considered as the control.  
Next, the sample solution containing the target DNA was deposited onto the sample pad 
of the LFA strip. Target DNA first hybridized with AuNP and detection probes (AuNP-DP) to 
form AuNP-DP-target DNA complex at the conjugate pad. Then the solution containing AuNP-
DP-target DNA complex migrated by capillary action, passing the glass fiber part of the strip 
into the test zone. At this point, a second hybridization took place between the AuNP-DP-target 
DNA complex and the capture probes, producing a red signal at the test zone, observable by the 
naked eyes (Figure 1.1). In the absence of target DNA in the sample solution, no colored signal 
is observed at the test zone. The excess complex then reached the control zone where 
hybridization with the control probe occurred, producing a second red signal observable at the 
control zone. The red signal at the control zone indicates that the tool is working (Figure 1.2). 
The tool was then placed in an incubator set at 69◦F (experiment 1) and 91◦F (experiment 
2). These temperatures correspond to the average range of temperature variation reported in 
regions of Sub-Saharan Africa and South Asia (National Centers for Environmental Information, 
2016). The presence or absence of a colored signal at the test and control zones was observed 
and noted at 5, 10, 15 and 30 minutes.  
4.2.3 Image analysis 
The LFA strips were imaged using an iPhone 6S Plus camera (Apple) on HDR (high 
dynamic imaging) mode. To obtain the same lighting, the pictures were taken at the same time 
and location on the laboratory bench. The strips were displayed on a blank sheet of white paper. 
The images were processed without modification. Image analysis followed the steps described in 
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Lathwal & Sikes (2008) supplemental publication. The color intensity of the signal at test and 
control zones were analyzed in RGB (red, green, and blue) color space using ImageJ software 
(National Institutes of Health). RGB is the most common color space used in image processing 
devices and corresponds to the red, green, and blue elemental components defining a color 
(Capitan-Vallvey et al., 2015). The darker an image is, the lower the color intensity; inversely, 
the lighter the image, the higher the color intensity.  
Each image was separated into a red, green, and blue channel. The minimum, maximum, 
and average intensity of the signal at the control and test zones were measured on each channel 
and the results were exported on MS Excel. Color intensity values of the signal was defined as 
the mean intensity of all three channels at the test and control zones. Statistical analysis was 
performed using Generalized Linear Model to evaluate the main effect of temperature, time and 
target DNA concentration on the color intensity. Color intensity was expressed as the log10 of 
the mean pixel value obtained from each channel.  
4.3 Results 
Colorimetric assessment of the signal was quantified as the mean color intensity of each 
RGB channel at the test and control zones. Comparison of the colorimetric responses, under each 
temperature, was done by tracking the changes in color intensity based on dilution series and 
time interval (5 and 10 minutes). While the tool was observed for a total of 30 minutes, we are 
only reporting on color change occurring within the first 10 minutes because no change was 
noted after that time point.  
4.3.1 Effect of time on color intensity  
69oF processing environment. A red signal was progressively observed at the test zone (Figure 
2). Color intensity values of the signal observed at the test and control zones were similar in each 
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RGB channels. So analysis of the colored intensity of the tool focused on the values obtained 
from the Red channel. Change in color intensity of the signal occurred progressively over the 
first 10 minutes, then remained constant. Except for the strip loaded with 1nM target DNA 
solution, red signal at the test zone was observed on all strips at 5 minutes after application of the 
sample solution. After 10 minutes, a light pink signal was also observable on the strip loaded 
with 1nM target DNA solution. These findings are suggestive that the optimal maximal time for 
colorimetric readout is 10 minutes when the tool is tested at 69◦F. 
91oF processing environment. In a 91◦F environment, a light pink signal was observed after five 
minutes at the test zone of the strips loaded with 10 and 25nM target DNA solution (Figure 1). 
On the remaining strips (loaded with 1nM, 100nM and 200nM target DNA solutions), no colored 
signal appeared at the test zone. At the control zone, reddish- pink signal was observable on each 
strip. Lowest colored intensity, i.e., darkest colored signal, was obtained on the strip loaded with 
10nM DNA concentration. After the first 10 minutes, a pink signal at the control zone of each 
strip was observed. No colored signal was observed at the test zone expect for two strips (loaded 
with 10 and 25nM target DNA solution).  
 Contrary to the results obtained under the 69◦F experiment, under 91◦F temperature, the 
signal reduced, i.e., lighter colored signal is observable at the test zone. The findings suggest less 
DNA hybridization at 91◦F. It seems that as temperature increases, the tool’s sensitivity 
decreases. 
4.3.2 Effect of concentration on color intensity 
Concentration series of the target DNA was also used to assess the effectiveness of the 
tool to detect the genetic material of targeted diarrheagenic pathogen in the two simulated 
environments. Concentration gradient ranged from a minimum of 1nM to maximum of 200nM, 
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and included dilution of the solution at 10nm, 25nm and 100nM. Observable red signal and their 
change in color intensity were recorded at both 5 and 10 minutes. Color intensity of the test zone 
decreased significantly by 3.8% in pixel value with every 1nM increase in target DNA 
concentration (p = 0.035) (Figure 3). The findings indicate that target DNA concentration at 10 
and 25nM concentration produced greatest color intensity; suggesting an increase hybridization 
rate between the target DNA and capture probe at the test zone with these concentrations. In 
addition, the results also suggest that the detection limit was achieved as low as 10nM and 
optimum colorimetric response was obtained at 25nM target DNA concentration.     
4.4 Discussion 
The present study is a feasibility study testing the sensitivity of a diarrhea pathogen 
identification tool to positively detect target sequence DNA of commercially available E. coli in 
two different temperature environments. The tool is a LFA strip using gold nanoparticle as a 
colorimetric probe to detect the presence of target DNA in the sample solution at different 
concentrations. Red signal was observed at the test and control zones when target sequence DNA 
solution is applied on the sample pad.   
Previous studies have been done testing LFA strips using AuNP based on time, 
temperature and target DNA concentration (Mao et al., 2009; Choi et al., 2016). In Mao and 
colleagues’ study (2009), the authors tested the sensitivity of a low-cost nucleic acid biosensor to 
detect commercial DNA based on time and target DNA oligos at various dilution series. Optimal 
time for detection was reported to be 15 minutes. Their study’s findings suggest a linear 
relationship between color intensity and concentration ranging from 1 to 100nM target DNA. 
When looking at temperature variation and its impact of the LFA ability to detect target nucleic 
acid, Choi et al. (2016) reported that optimal temperature for detection ranged between 131 and 
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140oF.   
In an environment of 69oF in our study, the tool showed the most visible signal at the 
control and test zones. Increase in temperature from 69oF to 91oF seemed to be linked with a 
decrease in color intensity of the red signal at the test zone. This may be due to various factors 
including, AuNP precipitation, evaporation of the sample solution or melting point of the primers 
or target DNA was reached or higher temperature might cause the double-stand DNA to 
dissociate, hence reducing the hybridization with the capture probe (Choi et al., 2016). 
We found the color intensity of the signal was negatively influenced by the target DNA 
concentration gradient. In 69oF environment, the lowest color intensity values corresponding to 
the darkest red signal was observed on the strips loaded with 10 and 25nM. The findings suggest 
that 10 minutes is the optimal colorimetric readout time and the detection limit is achieved at 
10nM while optimum red signal was achieved with 25nM target DNA concentration. 
4.4.1 Limitations 
This study assessed the tool sensitivity using only the target DNA of one bacterial species 
at two different temperature conditions. The experiments were not repeated to assess replicability 
and further validation of the tool. Additional optimization is needed at each step of development 
of the LFA strips to address these limitations. Sensitivity and specificity of the tool will be tested 
using various target DNA species at different concentration, as well as various concentration of 
reagents, capture probes and SSC buffer which can promote DNA hybridization.  Colorimetric 
assessment will be further explored as method of analysis. Future optimization of the tool will 
involve endogenous stool sample and testing the sensitivity at wider temperature variation and 
under other environmental condition such as humidity and stool acidity.  
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4.4.2 Implication for research and practice 
Future research will involve reproducing the experiment at ambient conditions and 
comparing it to various temperatures, target DNA concentrations and environmental conditions 
such as relative humidity and stool acidity. In addition, tool sensitivity will be tested using other 
commercial bacterial DNA and endogenous diarrhea and healthy stool. 
Diagnostics for poverty-related conditions such as diarrheal diseases are limited because 
they are mostly expansive and not adapted to the realities of many countries of the Developing 
World. Currently, management of diarrheal diseases are symptom based. However, this approach 
falls short to accurately identify the etiology and the severity of the disease as well as 
distinguishing asymptomatic diseases. Developing low cost, precise and user-friendly POC 
diagnostics is crucial in improving the management of diarrheal diseases at the bedside and the 
community level. Development of such tool has the potential to continue reducing the impact of 
diarrhea worldwide. 
4.5 Conclusion 
Diarrheal diseases remain the cause of millions of unnecessary deaths. Well-established 
interventions have proven to significantly reduce the mortality rates, but their impact have been 
limited in the last decade and even reversed in some areas. Identification of the etiologic agent 
causing a diarrheal episode will result in reduction of diarrhea related morbidity and mortality 
and prevent the unnecessary use of antibiotics. Existing standard diagnostics typically require 
expensive material, sophisticated infrastructure, and highly trained personnel.  POC testing has 
been at the center of investigation to address global health issues such as diarrhea. The properties 
of paper-based LFA offer the ability to develop low cost, rapid and accurate testing.  
This study is significant because it evaluates the effectiveness of a diarrheal pathogen 
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identification tool to positively detect the presence of pathogens causing diarrhea under 
laboratory simulated climatic conditions.  Testing the ability of the research tool under such 
conditions, in a controlled laboratory environment, allows identification of the tool’s limitation 
under high temperature. In addition, it also offers guidance for further optimization of the tool to 
make it more sensitive and specific.  The utilization of a simple, robust and accurate tool for the 
identification of diarrheal pathogens is important in addressing the burden of diarrhea 
worldwide. 
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Figure 1. Schematic illustration of the pathogen identification tool  
 
 
 
 
 
1) A. Sample solution containing target DNA is applied on the sample pad. Hybridization of 
target DNA with AuNP-DP to form AuNP-DP-target DNA complex. B. Migration of 
AuNP-DN-target DNA complex through the nitrocellulose membrane. C. Hybridization 
of AuNP-DP-target DNA with capture probe at the test zone. Hybridization of excess 
AuNP-DP-target DNA complex with control probe at control zone. 2)  Red signal 
observable at the test and control zones.  
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Figure 2. Effect of temperature, target DNA concentration and time on the pathogen 
identification tool 
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Figure 3. Main effect of Target DNA concentration on intensity of color signal  
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5.1 Introduction 
The ultimate goal of this dissertation was to contribute to our understanding of how the 
management of childhood diarrhea has evolved over the last four decades, to identify the major 
gaps in the current management and introduce a novel approach to address these gaps. The 
research in Chapters 2 and 3 examined the limited use of ORT and breastfeeding, interventions 
known to effectively prevent and treat diarrhea since the 1970’s. The study in Chapter 4 took a 
closer look at the properties of a pathogen identification tool for diarrhea in two laboratory 
simulated environments. 
5.2 Major findings from Chapter 2 
Observational studies reporting on physicians and pharmacists use of ORT in the 
management of childhood diarrhea in South Asia were systematically reviewed. The main 
objectives of the study was to assess what the literature reported on the use of ORT in treating 
cases of childhood diarrhea and comparing the prescription behaviors before and after the 
publication of the 2004 WHO guideline on the management of childhood diarrhea.  
A systematic review of the available evidence suggested significant variability in 
physicians and pharmacists reported ORT prescription rates in studies published before and after 
the 2004 WHO guideline. Physicians appeared to prescribe more frequently ORT compared to 
pharmacists. Reported knowledge and referencing of the WHO guideline for the management of 
childhood diarrhea and its recommended ORT formulation were limited. These findings 
reiterates the numerous reports on the limited use of ORT in the management of childhood 
diarrhea.  
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Most importantly, this study highlighted the methodological limitations of the published 
research and their reports. Inconsistencies in the quality of the data collection and reporting calls 
for the urgent need to develop standard methods to measure the outcomes, perform data 
collection and report the results. Studies with stronger methodology would have the potential to 
provide evidence that could identify the currents gaps and be the basis for the formulation of 
more effective interventions addressing global health issues such as diarrhea.  
5.3 Major findings from Chapter 3 
A secondary data analysis of the IFPS2 survey on breastfeeding cessation during the first 
6 months on the onset of diarrhea shows that: 1) breastfeeding for 6 months or more significantly 
decreases the incidence of diarrhea before the first year of life; 2) infants who breastfed for less 
than 3 months had the highest percentage of reported episodes of diarrhea at seven to 12 months; 
3) increase in maternal age, higher income households and higher maternal education were 
associated with a decrease in reported episodes of diarrhea episodes.  
Since it is free, breastfeeding is considered the most cost-effective intervention to prevent 
and treat diarrhea in infancy and early childhood. The results of the study reported in this chapter 
provides evidence supporting the practice of exclusive breastfeeding for the first 6 months of 
life. Infants who were breastfed for less than three months were the most affected by diarrhea 
which might be associated with early introduction of food other than breastmilk. Most 
importantly, the findings depicts the impact of social determinants such as education and 
household income on early breastfeeding cessation and subsequent onset of diarrheal episodes.  
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5.4 Major findings from Chapter 4 
Findings from Chapter 4 present the properties of a diarrheagenic pathogen identification 
tool to detect the presence of E coli at different dilution points. The tool was tested in laboratory 
environments simulating temperatures characteristic of region of the world that are the most 
affected by diarrhea. This feasibility study offers insight on the tool sensitivity based on 
temperature, time and concentration variations, allowing further optimization.  
The tool is a paper based lateral flow assay strip using gold nanoparticles as an indicator 
of the presence of a target pathogen. Positive detection of E. coli was translated by the presence 
of a hue of red colored signal at the test region on the strip. Ability to detect a pathogen was 
assessed by the presence or absence of a colored signal at the test and control zones, the time 
before observation of colored signal by the naked eyes and the color intensity of the signal.  
At 69oF, 10 minutes after the sample solution was applied, the tool was able to detect the 
presence of E. coli at a concentration varying from 1nM to 200nM. The colored signal were the 
darkest on the strips containing 10 and 25nM solutions. In a 91oF environment, the strips were 
only able to positively detect E. coli at 10 and 25nM after 5 minutes. Very light pink signal was 
visible on the test and control zones at these concentrations. Generalized linear regressions 
assessing the main effect of temperature, time and concentration on the color intensity suggested 
that concentration gradient had a negative relation on the color intensity signal visible on the 
strip.  
These findings suggest that optimal detection of bacterial DNA occurs at concentration 
between 10 and 25nM, 10 minutes after the initial application of the sample solution. 
Temperature and increase in DNA concentration appear to limit the detection properties of the 
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tool. The results will guide further optimization of the tool to ultimately become reliable and 
relevant to resource-limited settings.  
5.5 Limitations 
The studies in this dissertation have several limitations. First the study in Chapter 2 is 
based on the existing peer- reviewed literature limited to English language. Quality of the articles 
included in the review was not assessed, which increase the risk of bias from inclusion of studies 
with misrepresentative findings. Across studies, measurement of ORT prescriptions was 
inconsistent. The studies differed greatly in their design and methodology, population and 
settings. This variation limited the availability of quality data; hence unabling combination of the 
studies’ findings into a meta-analysis and identification of defined ORT prescription patterns 
across countries, settings and time periods. 
Second, due to the nature of the data, i.e secondary data analysis, the study in Chapter 3 
has some limitations. The major challenge was the fact that the study’s population was not 
representative of the US population, so the findings could not be generalized at the national 
level. In addition, the lack of data collected between the neonatal period and month 3 was a 
missed opportunity to depict a clearer picture of early breastfeeding cessation and potential 
influencing factors. Nationally representative studies with quality data collected monthly from 
birth would produce stronger evidence on the preventive properties of breastfeeding on 
childhood diarrhea. 
The major limitation of the study in Chapter 4 is the sample size. Only one sample 
solution was used to test the tools’ properties. Therefore, evaluation of the potential effect of 
temperature, concentration and time on the color intensity is limited. Further test will be 
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performed using commercial DNA of other bacteria such as Clostridium difficile and endogenous 
stool sample under diverse environmental conditions such as wider temperature range, relative 
humid and stool acidity.  
5.6 Implication for policy and practice 
The findings highlight the magnitude of inconsistencies in the current management of 
childhood diarrhea and the need to develop alternative approach to contain the effect of the 
health condition on the most vulnerable. The research furthers previous studies and international 
institutions’ efforts to address the limited use of ORT and breastfeeding in the management of 
diarrhea for the profit of unnecessary use of antibiotics and others therapies. These findings 
support the on-going development of new technologies, economic and requiring minimal 
instrumentation, to address global health issues.  
In resource limited settings, where the medical system lacks modern laboratory 
infrastructures and trained human resource, user-friendly technologies are urgently needed to 
improve therapeutic management.  The development of low cost lateral- flow immunoassays 
used to identify etiologic agents causing diarrhea diseases, offers considerable potential to reduce 
the burden of the disease and change the current practice guideline which is symptom based 
(Yetisen, Akram, & Lowe, 2013). In addition, distinguishing bacterial from viral diarrheal 
episodes would better inform healthcare providers to make the right prescriptions, hence 
reducing the risk to unnecessarily prescribe antibiotics. 
Regardless of the advances in health and technology, the porosity of geographical 
boundaries and population migration due to globalization, foodborne illnesses, zoonotic and 
waterborne diseases remain health issues that continue to fuel diarrheal diseases. This is mainly 
 
 
82 
 
due to limited access to clean water and adequate sanitation, close human-animal contact and 
ingestion of contaminated food. Programs testing the food and water supplies designated for 
human consumption are limited in developing countries. Development of such tests has the 
potential to play an essential role in medical diagnosis, food safety and control as well as 
environmental monitoring for prevention and control of epidemics (Yetisen et al., 2013).  
5.7 Implication for research 
Given this dissertation’s findings, two areas for future research were mainly defined. First 
and most importantly, there is an urgent need to design and perform observational studies with 
strong methodology, data collection and reporting. Standard guideline for global health research 
based on conceptual framework could be defined by international institution such as the WHO to 
insure actions based on quality evidence and report of the findings. Research settings might 
differ greatly based on the culture, language and demographics, but regardless of these 
distinguishing features, common factors are associated with diarrhea. Therefore, overarching 
guideline could be develop to collect and measure outcomes related to diarrheal diseases.  
Multicountry surveys such as the Demographic Health Survey and Multiple Indicator 
Cluster Survey (MICS) can also contribute to our understanding of global health issues as they 
occur in the natural settings. Managed by the United States Agency for International 
Development, DHS consists of numerous surveys lead to monitor and evaluate different 
indicators of countries’ needs (Rutstein & Rojas, 2006). The analysis of such large dataset can be 
another alternative to picture the prevalence of health behaviors such as diarrhea management.   
Second area of research is the development of alternative platform technologies that 
could address the identified gaps in the management of childhood diarrhea. The WHO has set 
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seven criteria for the development of point of care diagnostic tests for resources-limited settings 
(Kettler et al., 2004). These characteristics should guide research and prioritize the development 
of low cost, rapid, sensitive and specific diagnostic assays. Besides the development of new 
diagnostics, more scientific efforts should be invested in ensuring that these technologies are 
adapted to the climate and environment specific to resource-limited settings.  
5.8 Conclusion 
A shift in priority away from diarrhea management has contributed to the slowing 
progress in the full coverage of ORT and breastfeeding as preventive and treatment measures. 
The development of point-of-care diagnostics at the service of global health issues is critical to 
address the gap in using adequate management measures, hence improving child survival and 
reducing morbidity and mortality rates caused by diarrheal diseases. Understanding the 
fundamentals of capillary flow of the paper-based assays, detection of bacterial genetic material 
and other characteristics of the technology will allow development of assays with better control 
over the impact of temperature, moisture and other environmental factors.  
The characteristics of paper and potential simplicity of the tool offer the potential for this 
paper-based lateral flow assay to be utilized in settings with very limited resources while offering 
accurate and highly sensitive information. However, having laboratory controlled data does not 
always yield to accurate performance of the tool once deployed in the real world. Testing the 
specificity and sensitivity of the tool in different clinical and community settings is required in 
order to produce strong evidence to adopt the test within the standard management of diarrhea. 
Such research will allow transformation of the tool from a prototype into a reproducible 
diagnostic platform. 
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